• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Efficacy of the transcatheter tricuspid valve replacement for patients with severe tricuspid regurgitation: Lux-Valve versus Lux-Valve Plus].经导管三尖瓣置换术治疗重度三尖瓣反流患者的疗效:LUX瓣膜与LUX瓣膜升级版对比
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Mar 25;54(2):213-218. doi: 10.3724/zdxbyxb-2024-0365.
2
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial.经导管三尖瓣置换术后的生活质量:TRISCEND II 关键试验的 1 年结果
J Am Coll Cardiol. 2025 Jan 28;85(3):206-216. doi: 10.1016/j.jacc.2024.10.067. Epub 2024 Oct 30.
3
Transjugular Transcatheter Tricuspid Valve Replacement: Early Compassionate Use Outcomes.经颈静脉经导管三尖瓣置换术:早期同情使用结果。
JACC Cardiovasc Interv. 2024 Aug 26;17(16):1936-1945. doi: 10.1016/j.jcin.2024.06.014.
4
Comparing outcomes of transcatheter tricuspid valve replacement and medical therapy for symptomatic severe tricuspid regurgitation: a retrospective study.经导管三尖瓣置换术与药物治疗症状性重度三尖瓣反流的结局比较:一项回顾性研究。
Eur J Med Res. 2024 Aug 5;29(1):407. doi: 10.1186/s40001-024-01947-9.
5
Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation.经导管三尖瓣置换术治疗重度三尖瓣反流患者。
Heart. 2021 Oct;107(20):1664-1670. doi: 10.1136/heartjnl-2020-318199. Epub 2021 Jan 8.
6
[Safety and efficacy of transcatheter tricuspid valve replacement with LuX-Valve in patients with severe tricuspid regurgitation].[经导管使用LuX瓣膜置换术治疗严重三尖瓣反流患者的安全性和有效性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 May 24;49(5):455-460. doi: 10.3760/cma.j.cn112148-20210125-00091.
7
[Feasibility study of transjugular tricuspid valve replacement for the treatment of tricuspid regurgitation].
Zhonghua Xin Xue Guan Bing Za Zhi. 2025 Apr 24;53(4):363-372. doi: 10.3760/cma.j.cn112148-20250127-00072.
8
Impact of transcatheter tricuspid valve replacement for tricuspid regurgitation on hepatic, cardiac, and venous structure.经导管三尖瓣置换术治疗三尖瓣反流对肝脏、心脏和静脉结构的影响。
Int J Cardiol. 2023 Feb 1;372:33-39. doi: 10.1016/j.ijcard.2022.11.057. Epub 2022 Nov 28.
9
Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement.经导管三尖瓣置换的早期单部位经验。
JACC Cardiovasc Imaging. 2019 Mar;12(3):416-429. doi: 10.1016/j.jcmg.2018.08.034. Epub 2018 Dec 12.
10
Comparison of clinical and echocardiographic outcomes between mini-thoracotomy transatrial LuX-Valve transcatheter and surgical tricuspid valve replacement.经胸小切口经心房LuX-Valve经导管与外科三尖瓣置换术的临床和超声心动图结果比较。
Front Cardiovasc Med. 2024 Aug 5;11:1417757. doi: 10.3389/fcvm.2024.1417757. eCollection 2024.

本文引用的文献

1
Isolated Tricuspid Operations: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis.单纯三尖瓣手术:胸外科医师学会成人心脏外科学数据库分析。
Ann Thorac Surg. 2023 May;115(5):1162-1170. doi: 10.1016/j.athoracsur.2022.12.041. Epub 2023 Jan 22.
2
4-Year Follow-Up after Transatrial Transcatheter Tricuspid Valve Replacement with the LuX-Valve.使用LuX瓣膜经心房经导管三尖瓣置换术后4年随访
J Cardiovasc Dev Dis. 2022 Dec 4;9(12):435. doi: 10.3390/jcdd9120435.
3
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies.孤立性三尖瓣置换术的结局:35 项研究中 5316 例患者的系统评价和荟萃分析。
EuroIntervention. 2022 Nov 18;18(10):840-851. doi: 10.4244/EIJ-D-22-00442.
4
Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation.经导管三尖瓣置换术治疗重度三尖瓣反流患者。
Heart. 2021 Oct;107(20):1664-1670. doi: 10.1136/heartjnl-2020-318199. Epub 2021 Jan 8.
5
Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options.三尖瓣反流的机制及影响:从病理生理学到当前及未来的治疗选择
Circ Cardiovasc Interv. 2017 Jul;10(7). doi: 10.1161/CIRCINTERVENTIONS.117.005043.

经导管三尖瓣置换术治疗重度三尖瓣反流患者的疗效:LUX瓣膜与LUX瓣膜升级版对比

[Efficacy of the transcatheter tricuspid valve replacement for patients with severe tricuspid regurgitation: Lux-Valve versus Lux-Valve Plus].

作者信息

Sun Yandan, Cao Liang, Bai Wei, Li Yuxi, Yang Jian, Jiang Guomeng, Liu Yang, Jin Ping, Liu Liwen, Meng Xin

机构信息

Department of Ultrasound Medicine, the First Affiliated Hospital of the Air Force Medical University (Xijing Hospital), Xi'an 710032, China.

Department of Ultrasonography, the 986th Hospital of the Air Force Medical University, Xi'an 710054, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Mar 25;54(2):213-218. doi: 10.3724/zdxbyxb-2024-0365.

DOI:10.3724/zdxbyxb-2024-0365
PMID:40159401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12062938/
Abstract

OBJECTIVES

To compare the efficacy of transcatheter tricuspid valve replacement (TTVR) using Lux-Valve and Lux-Valve Plus in patients with severe tricuspid regurgitation.

METHODS

A total of 28 consecutive patients with severe tricuspid regurgitation who underwent TTVR with Lux-Valve (=14) or Lux-Valve Plus (=14) in the First Affiliated Hospital of the Air Force Medical University from August 2019 to November 2023 were enrolled. Transthoracic echocardiography was performed in all patients before and 6 months after the TTVR. The ultrasound indexes were compared before and 6 months after the TTVR in all patients and between Lux-Valve and Lux-Valve Plus groups.

RESULTS

Compared with the Lux-Valve group, the Lux-Valve Plus group showed significantly reduced intraoperative bleeding and shorter postoperative hospital stays (both <0.05). Six months after the TTVR, none of the patients exhibited more than a mild tricuspid valve regurgitation, and none of the patients had moderate or above perivalvular leakage except for one patient in the Lux-Valve Plus group who had a separation of the clamping member from the anterior tricuspid leaflet. The incidence of perivalvular leakage was significantly lower in the Lux-Valve Plus group (14.29%, 2/14) than in the Lux-Valve group (64.29%, 9/14, <0.05). At 6 months after operation, the right chamber volume and right ventricle middle transverse diameter were reduced (both <0.05); the peak blood flow velocity across the tricuspid valve, peak pressure gradient across the tricuspid valve, mean blood flow velocity of tricuspid valve, mean pressure gradient across the tricuspid valve and velocity time integral were increased in both groups (all <0.05).Compared with the Lux-Valve group, the Lux-Valve Plus group showed higher left ventricular ejection fraction at 6 months postoperatively (<0.05), while the rest of the indicators were not statistically different (all >0.05).

CONCLUSIONS

The efficacy of using Lux-Valve and Lux-Valve Plus for TTVR in patients with severe tricuspid regurgitation is comparable. Six months after the TTVR, the right side of the heart has undergone reverse remodeling.While Lux-Valve Plus offers greater minimally invasive benefits, valve selection should consider device-specific characteristics and differences in individual patients.

摘要

目的

比较使用Lux-Valve和Lux-Valve Plus经导管三尖瓣置换术(TTVR)治疗严重三尖瓣反流患者的疗效。

方法

纳入2019年8月至2023年11月在空军军医大学第一附属医院连续接受Lux-Valve(n = 14)或Lux-Valve Plus(n = 14)TTVR治疗的28例严重三尖瓣反流患者。所有患者在TTVR术前和术后6个月进行经胸超声心动图检查。比较所有患者TTVR术前和术后6个月以及Lux-Valve组和Lux-Valve Plus组之间的超声指标。

结果

与Lux-Valve组相比,Lux-Valve Plus组术中出血明显减少,术后住院时间缩短(均P<0.05)。TTVR术后6个月,所有患者均未出现超过轻度的三尖瓣反流,除Lux-Valve Plus组1例患者出现夹持部件与三尖瓣前叶分离外(该患者有中度或以上瓣周漏),其余患者均无中度或以上瓣周漏。Lux-Valve Plus组瓣周漏发生率(14.29%,2/14)明显低于Lux-Valve组(64.29%,9/14,P<0.05)。术后6个月,右心房容积和右心室中部横径减小(均P<0.05);两组三尖瓣跨瓣血流峰值速度、三尖瓣跨瓣峰值压力阶差、三尖瓣平均血流速度、三尖瓣平均压力阶差和速度时间积分均增加(均P<0.05)。与Lux-Valve组相比,Lux-Valve Plus组术后6个月左心室射血分数更高(P<0.05),而其余指标差异无统计学意义(均P>0.05)。

结论

使用Lux-Valve和Lux-Valve Plus进行TTVR治疗严重三尖瓣反流患者的疗效相当。TTVR术后6个月,心脏右侧发生逆向重塑。虽然Lux-Valve Plus具有更大的微创优势,但瓣膜选择应考虑器械的特定特征和个体患者差异。